These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12433438)

  • 1. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
    El-Shabouri MH
    Int J Pharm; 2002 Dec; 249(1-2):101-8. PubMed ID: 12433438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.
    Lai J; Lu Y; Yin Z; Hu F; Wu W
    Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.
    Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W
    Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
    Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
    Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
    Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
    J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the cyclosporin A loaded stearic acid nanoparticles.
    Zhang Q; Yie G; Li Y; Yang Q; Nagai T
    Int J Pharm; 2000 May; 200(2):153-9. PubMed ID: 10867245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
    Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
    Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.
    Meng J; Hu L
    J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
    Yang SG; Kim DD; Chung SJ; Shim CK
    Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin nanoparticulate lipospheres for oral administration.
    Bekerman T; Golenser J; Domb A
    J Pharm Sci; 2004 May; 93(5):1264-70. PubMed ID: 15067702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.
    Zhang L; Zhao ZL; Wei XH; Liu JH
    Int J Nanomedicine; 2013; 8():601-10. PubMed ID: 23429854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
    Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
    Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
    Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
    Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
    Hirunpanich V; Sato H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
    Guan P; Lu Y; Qi J; Wu W
    Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
    Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
    Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats].
    Wang XQ; Zhang T; He Y; Zhang L; Zhang Q
    Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
    Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
    Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
    Yang ZQ; Xu J; Pan P; Zhang XN
    Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.
    Guo J; Ping Q; Chen Y
    Int J Pharm; 2001 Mar; 216(1-2):17-21. PubMed ID: 11274802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.